MX2016014050A - Combinacion de un acido hialuronico y un polisacarido sulfatado. - Google Patents

Combinacion de un acido hialuronico y un polisacarido sulfatado.

Info

Publication number
MX2016014050A
MX2016014050A MX2016014050A MX2016014050A MX2016014050A MX 2016014050 A MX2016014050 A MX 2016014050A MX 2016014050 A MX2016014050 A MX 2016014050A MX 2016014050 A MX2016014050 A MX 2016014050A MX 2016014050 A MX2016014050 A MX 2016014050A
Authority
MX
Mexico
Prior art keywords
combination
hyaluronic acid
sulphated polysaccharide
sulphated
polysaccharide
Prior art date
Application number
MX2016014050A
Other languages
English (en)
Spanish (es)
Inventor
Poigny Stéphane
Hernandez-Pigeon Hélène
Hilaire Saurat Jean-
Kaya Gürkan
Original Assignee
Pierre Fabre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique filed Critical Pierre Fabre Dermo Cosmetique
Publication of MX2016014050A publication Critical patent/MX2016014050A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2016014050A 2014-04-30 2015-04-30 Combinacion de un acido hialuronico y un polisacarido sulfatado. MX2016014050A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1453973A FR3020570B1 (fr) 2014-04-30 2014-04-30 Association d'un acide hyaluronique et d'un polysaccharide sulfate
PCT/EP2015/059544 WO2015166063A1 (fr) 2014-04-30 2015-04-30 Association d'un acide hyaluronique et d'un polysaccharide sulfate

Publications (1)

Publication Number Publication Date
MX2016014050A true MX2016014050A (es) 2017-02-14

Family

ID=50976947

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014050A MX2016014050A (es) 2014-04-30 2015-04-30 Combinacion de un acido hialuronico y un polisacarido sulfatado.

Country Status (12)

Country Link
US (1) US9993417B2 (enExample)
EP (1) EP3137050B1 (enExample)
JP (1) JP6625558B2 (enExample)
KR (1) KR20160145788A (enExample)
CN (1) CN106255490B (enExample)
AU (1) AU2015254602B2 (enExample)
BR (1) BR112016024161B1 (enExample)
CA (1) CA2946943C (enExample)
FR (1) FR3020570B1 (enExample)
MX (1) MX2016014050A (enExample)
RU (1) RU2683567C2 (enExample)
WO (1) WO2015166063A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106038355B (zh) * 2016-07-21 2019-11-12 中国科学院海洋研究所 一种高硫酸化的海藻多糖在晒后修复面膜中的应用
WO2019022250A1 (ja) * 2017-07-28 2019-01-31 国立大学法人九州大学 水溶性有効成分の放出が制御された経皮吸収組成物
FR3075644B1 (fr) * 2017-12-27 2020-08-28 Oreal Oligosaccharides sulfates et leurs utilisations cosmetiques
CN108553481B (zh) * 2018-05-25 2020-11-13 中国海洋大学 一种具有促进伤口愈合作用的糖类组合物及其应用
SG11202100393TA (en) * 2018-07-27 2021-02-25 Arc Medical Devices Inc Highly purified fucans for the treatment of fibrous adhesions
FR3098723B1 (fr) * 2019-07-18 2023-01-13 Bionuclei Traitement ecobiologique des effets secondaires de la radiotherapie.
RU2753638C2 (ru) * 2020-01-24 2021-08-18 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НОВАСКИН" (ООО "Новаскин") Гелевая композиция для обработки кожных покровов
FR3113236B1 (fr) * 2020-08-05 2024-10-04 Algues Et Mer Fraction purifiée de fucoïdanes pour la préparation de compositions cosmétiques et/ou dermatologiques anti-age.
IT202000022477A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
CN115040535B (zh) * 2022-08-15 2022-12-16 华南理工大学 硫酸化透明质酸在制备预防角膜纤维化、角膜瘢痕滴眼液中的应用
WO2024090341A1 (ja) 2022-10-25 2024-05-02 国立大学法人高知大学 アンチエイジング剤

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
KR970705401A (ko) * 1994-08-30 1997-10-09 사무엘 시몬 에스큘라이 세포활성의 조정용 히알루론산과 그 유도체(hyaluronic acid and derivatives for modulation of cellular activity)
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
FR2775976B1 (fr) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
US6572868B1 (en) * 2000-07-25 2003-06-03 Sandra E. Cope Restructuring complex for cosmetic compositions
FR2829762B1 (fr) * 2001-09-17 2004-02-13 Fabre Pierre Dermo Cosmetique Bioprecurseurs destines a une application percutanee
KR100485326B1 (ko) * 2002-12-26 2005-04-27 주식회사 태평양 진세노사이드 화합물 ｋ로 이루어진 히알루론산 생성촉진제
US6925626B2 (en) * 2003-08-13 2005-08-02 Lsi Logic Corporation Method of routing a redistribution layer trace in an integrated circuit die
FR2865651B1 (fr) * 2004-01-29 2007-09-28 Fabre Pierre Dermo Cosmetique Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
US20080038780A1 (en) 2006-02-15 2008-02-14 Novozymes Biopolymer A/S Production of low molecular weight hyaluronic acid
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
DE102006060953A1 (de) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
KR20080087941A (ko) * 2007-03-28 2008-10-02 주식회사 바이오랜드 저분자량 히알우론산을 함유하는 피부주름개선 및각질제거용 조성물
JP5468757B2 (ja) * 2007-09-04 2014-04-09 ロート製薬株式会社 線維芽細胞増殖促進能を有する組成物
CZ303471B6 (cs) * 2007-10-03 2012-10-03 Contipro Biotech S.R.O. Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan
US7932237B2 (en) * 2008-05-15 2011-04-26 Consejo Nacional De Investigaciones Cientificas Y Technicas (CONICET) Pharmaceutical compositions for use in the treatment of wounds
KR20100025237A (ko) * 2008-08-27 2010-03-09 주식회사 해림후코이단 후코이단을 함유하는 아토피성 피부용 보습제
WO2010086696A1 (en) 2009-01-28 2010-08-05 Therapol Low-molecular-weight sulphated polysaccharides as candidates for anti-angiogenic therapy
KR101149711B1 (ko) * 2010-02-25 2012-06-08 (주)코스비전 저분자 후코이단, 비타민나무 추출물 및 니아신아마이드가 함유된 피부 미백용 화장료 조성물 및 그 제조방법
KR20130018739A (ko) * 2010-03-03 2013-02-25 네오큐티스 에스아 항균 펩티드 격리 화합물을 사용한 피부 질환 및 장애의 치료를 위한 조성물 및 방법
FR2958157B1 (fr) * 2010-04-02 2012-06-29 Libragen Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate
FR2978664B1 (fr) * 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique
JP5946253B2 (ja) * 2011-08-10 2016-07-06 ロート製薬株式会社 弾性線維形成促進剤
FR2988606B1 (fr) * 2012-03-30 2014-08-08 Sederma Sa Composition topique comprenant des oligosaccharides sulfates bioactifs et utilisations cosmetiques
FR2989087B1 (fr) * 2012-04-06 2016-01-01 Greentech Nouveaux composes oligosaccharides et leur utilisation cosmetique

Also Published As

Publication number Publication date
BR112016024161A2 (pt) 2017-08-15
CA2946943C (fr) 2022-06-21
EP3137050B1 (fr) 2020-03-04
JP2017514825A (ja) 2017-06-08
CN106255490B (zh) 2019-10-01
WO2015166063A1 (fr) 2015-11-05
US20170049678A1 (en) 2017-02-23
RU2683567C2 (ru) 2019-03-29
CN106255490A (zh) 2016-12-21
BR112016024161B1 (pt) 2021-03-02
RU2016146372A3 (enExample) 2018-10-03
KR20160145788A (ko) 2016-12-20
AU2015254602B2 (en) 2019-10-24
RU2016146372A (ru) 2018-05-31
JP6625558B2 (ja) 2019-12-25
AU2015254602A1 (en) 2016-12-22
FR3020570B1 (fr) 2017-07-21
FR3020570A1 (fr) 2015-11-06
US9993417B2 (en) 2018-06-12
EP3137050A1 (fr) 2017-03-08
CA2946943A1 (fr) 2015-11-05

Similar Documents

Publication Publication Date Title
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
MX2017011241A (es) Metodos para tratar la piel.
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
PE20171138A1 (es) Modulacion inmunitaria
SV2018005714A (es) Composiciones y metodos para disminuir la expresion de tau
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
BR112017010177A2 (pt) composição para tratamento de tecido
MX2017004198A (es) Composiciones y equipos para tratar prurito y metodos para utilizar los mismos.
MX2018007871A (es) Composiciones para el cuidado personal.
CL2016000544A1 (es) Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel.
MX2022005370A (es) Analogos de compstatina de accion prolongada para usarse en el tratamiento de trastornos oculares.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
CL2016002779A1 (es) Composición para el cuidado de la piel
MX381252B (es) Virus de la enteritis del pato y usos del mismo.
EA201690936A1 (ru) Применение цистеамина и его производных для лечения митохондриальных заболеваний
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
MX2017008823A (es) Metodos para aislamiento de plaquetas.
MX2017002796A (es) Tasimelteon para tratar el sindrome de smith-magenis.
MX376176B (es) Composiciones para el tratamiento de autodigestion.
DOP2017000014A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
CL2017000178A1 (es) Compuestos para usar en el tratamiento antihelmíntico
CL2018002128A1 (es) Composiciones y métodos para el tratamiento de heridas crónicas
CY1122457T1 (el) Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας
AR093689A1 (es) Una composicion para la preparacion de acido hialuronico reticulado viscoelastico, y acido hialuronico reticulado obtenido al usar la misma

Legal Events

Date Code Title Description
FG Grant or registration